 Amit Ketkar
Concepts (130)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA-Directed DNA Polymerase | 13 | 2021 | 89 | 2.430 |
Why?
| | DNA | 7 | 2021 | 544 | 1.390 |
Why?
| | G-Quadruplexes | 5 | 2021 | 77 | 1.340 |
Why?
| | Indoles | 4 | 2019 | 283 | 0.940 |
Why?
| | DNA Replication | 5 | 2021 | 159 | 0.890 |
Why?
| | Nucleotidyltransferases | 2 | 2021 | 16 | 0.790 |
Why?
| | Enzyme Inhibitors | 3 | 2019 | 378 | 0.730 |
Why?
| | DNA Damage | 4 | 2019 | 298 | 0.600 |
Why?
| | Werner Syndrome | 1 | 2017 | 14 | 0.520 |
Why?
| | Models, Molecular | 5 | 2021 | 356 | 0.480 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 2 | 2013 | 15 | 0.420 |
Why?
| | Antineoplastic Agents | 6 | 2018 | 1216 | 0.420 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2013 | 4 | 0.400 |
Why?
| | Leukotrienes | 1 | 2013 | 9 | 0.400 |
Why?
| | Deoxyribonucleotides | 1 | 2012 | 4 | 0.390 |
Why?
| | Stilbenes | 4 | 2018 | 58 | 0.390 |
Why?
| | Sulfolobus solfataricus | 1 | 2012 | 22 | 0.380 |
Why?
| | Nucleic Acid Conformation | 1 | 2012 | 84 | 0.380 |
Why?
| | Nucleotides | 1 | 2012 | 24 | 0.380 |
Why?
| | Molecular Docking Simulation | 6 | 2018 | 93 | 0.330 |
Why?
| | Deoxyguanosine | 3 | 2021 | 27 | 0.320 |
Why?
| | Kinetics | 6 | 2016 | 613 | 0.210 |
Why?
| | DNA Repair | 2 | 2017 | 194 | 0.210 |
Why?
| | RecQ Helicases | 2 | 2014 | 21 | 0.210 |
Why?
| | Cell Line | 3 | 2021 | 1020 | 0.200 |
Why?
| | Nuclear Proteins | 2 | 2015 | 247 | 0.200 |
Why?
| | Mutation | 2 | 2021 | 1331 | 0.200 |
Why?
| | Protein Binding | 3 | 2021 | 673 | 0.190 |
Why?
| | Humans | 19 | 2021 | 52441 | 0.180 |
Why?
| | Inositol | 1 | 2021 | 18 | 0.180 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2021 | 34 | 0.180 |
Why?
| | Mitochondrial Dynamics | 1 | 2021 | 22 | 0.180 |
Why?
| | Inhibitory Concentration 50 | 2 | 2019 | 74 | 0.180 |
Why?
| | Oligonucleotides | 1 | 2021 | 76 | 0.180 |
Why?
| | Substrate Specificity | 4 | 2015 | 197 | 0.170 |
Why?
| | Nucleotide Motifs | 1 | 2021 | 22 | 0.170 |
Why?
| | Genes, myc | 1 | 2021 | 39 | 0.170 |
Why?
| | Alkylation | 1 | 2019 | 9 | 0.150 |
Why?
| | Drug Screening Assays, Antitumor | 5 | 2018 | 135 | 0.150 |
Why?
| | Tubulin Modulators | 2 | 2016 | 28 | 0.140 |
Why?
| | Cell Line, Tumor | 6 | 2018 | 1429 | 0.140 |
Why?
| | Binding Sites | 3 | 2015 | 379 | 0.140 |
Why?
| | Thiobarbiturates | 2 | 2018 | 22 | 0.140 |
Why?
| | Small Molecule Libraries | 2 | 2018 | 66 | 0.130 |
Why?
| | Molecular Structure | 4 | 2021 | 317 | 0.130 |
Why?
| | Naphthalenes | 1 | 2018 | 120 | 0.130 |
Why?
| | Receptors, Opioid, delta | 1 | 2016 | 25 | 0.130 |
Why?
| | Morphine Derivatives | 1 | 2016 | 27 | 0.120 |
Why?
| | Exodeoxyribonucleases | 2 | 2014 | 20 | 0.120 |
Why?
| | Dioxanes | 1 | 2016 | 10 | 0.120 |
Why?
| | Receptors, Opioid, mu | 1 | 2016 | 52 | 0.120 |
Why?
| | Acetonitriles | 1 | 2016 | 7 | 0.120 |
Why?
| | Morphine | 1 | 2016 | 104 | 0.120 |
Why?
| | Cisplatin | 1 | 2018 | 282 | 0.120 |
Why?
| | Barbiturates | 1 | 2015 | 17 | 0.120 |
Why?
| | Up-Regulation | 2 | 2014 | 462 | 0.120 |
Why?
| | Analgesics | 1 | 2016 | 106 | 0.120 |
Why?
| | Benzodioxoles | 1 | 2016 | 40 | 0.120 |
Why?
| | DNA Polymerase II | 1 | 2015 | 9 | 0.120 |
Why?
| | Tubulin | 1 | 2014 | 22 | 0.110 |
Why?
| | Heterocyclic Compounds | 1 | 2014 | 29 | 0.110 |
Why?
| | DNA Primase | 1 | 2014 | 8 | 0.110 |
Why?
| | Biocatalysis | 1 | 2014 | 15 | 0.110 |
Why?
| | Triazoles | 1 | 2015 | 115 | 0.110 |
Why?
| | Manganese | 1 | 2014 | 22 | 0.110 |
Why?
| | Magnesium | 1 | 2014 | 35 | 0.110 |
Why?
| | Structure-Activity Relationship | 4 | 2018 | 399 | 0.110 |
Why?
| | DNA Adducts | 1 | 2014 | 79 | 0.110 |
Why?
| | Carbohydrate Conformation | 1 | 2012 | 4 | 0.100 |
Why?
| | Deoxyadenine Nucleotides | 1 | 2012 | 4 | 0.100 |
Why?
| | DNA, Archaeal | 1 | 2012 | 10 | 0.100 |
Why?
| | Catalytic Domain | 1 | 2012 | 61 | 0.100 |
Why?
| | Crystallography, X-Ray | 1 | 2012 | 158 | 0.090 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2012 | 17 | 0.090 |
Why?
| | Cell Proliferation | 4 | 2018 | 1013 | 0.090 |
Why?
| | Adenosine Triphosphate | 1 | 2012 | 234 | 0.090 |
Why?
| | Spinal Cord | 1 | 2012 | 169 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2012 | 137 | 0.090 |
Why?
| | Proteome | 1 | 2012 | 175 | 0.080 |
Why?
| | DNA Primers | 3 | 2015 | 204 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2018 | 1365 | 0.070 |
Why?
| | DNA, Single-Stranded | 1 | 2008 | 88 | 0.070 |
Why?
| | Escherichia coli | 1 | 2008 | 182 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 180 | 0.060 |
Why?
| | Stress, Physiological | 2 | 2021 | 183 | 0.060 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2008 | 176 | 0.060 |
Why?
| | Stereoisomerism | 2 | 2016 | 100 | 0.060 |
Why?
| | Protein Structure, Tertiary | 2 | 2015 | 260 | 0.060 |
Why?
| | Rats | 3 | 2016 | 3228 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 1888 | 0.050 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2021 | 23 | 0.050 |
Why?
| | Animals | 4 | 2021 | 13485 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 245 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 255 | 0.040 |
Why?
| | Phosphorylation | 1 | 2021 | 536 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2021 | 903 | 0.040 |
Why?
| | Mitochondria | 1 | 2021 | 420 | 0.030 |
Why?
| | Mice | 2 | 2021 | 5899 | 0.030 |
Why?
| | Fluorescence Polarization | 1 | 2016 | 17 | 0.030 |
Why?
| | Pyrimidines | 1 | 2018 | 199 | 0.030 |
Why?
| | Cricetulus | 1 | 2016 | 100 | 0.030 |
Why?
| | Receptors, Opioid, kappa | 1 | 2016 | 38 | 0.030 |
Why?
| | CHO Cells | 1 | 2016 | 123 | 0.030 |
Why?
| | Cricetinae | 1 | 2016 | 189 | 0.030 |
Why?
| | Drug Tolerance | 1 | 2016 | 60 | 0.030 |
Why?
| | Base Pair Mismatch | 1 | 2015 | 21 | 0.030 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 136 | 0.030 |
Why?
| | Templates, Genetic | 1 | 2014 | 12 | 0.030 |
Why?
| | Deoxycytidine Monophosphate | 1 | 2013 | 5 | 0.030 |
Why?
| | HeLa Cells | 1 | 2014 | 243 | 0.030 |
Why?
| | Guanine | 1 | 2013 | 39 | 0.030 |
Why?
| | Pain | 1 | 2016 | 373 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2014 | 490 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 1558 | 0.020 |
Why?
| | Catalysis | 1 | 2012 | 88 | 0.020 |
Why?
| | Antigen Presentation | 1 | 2012 | 25 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2012 | 49 | 0.020 |
Why?
| | Cysteine Endopeptidases | 1 | 2012 | 65 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2012 | 89 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2016 | 601 | 0.020 |
Why?
| | Apoptosis | 1 | 2015 | 1120 | 0.020 |
Why?
| | Proteomics | 1 | 2012 | 332 | 0.020 |
Why?
| | Male | 2 | 2021 | 26874 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 59 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2008 | 67 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2008 | 140 | 0.020 |
Why?
| | Neoplasms | 1 | 2018 | 1314 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2008 | 576 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 778 | 0.020 |
Why?
| | Female | 1 | 2012 | 28277 | 0.010 |
Why?
|
|
Ketkar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|